These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 9422538)

  • 21. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
    Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
    Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical detection of E2F-1 in non-Hodgkin's lymphomas: a survey of 124 cases.
    Lai R; Medeiros LJ; Coupland R; McCourty A; Brynes RK
    Mod Pathol; 1998 May; 11(5):457-63. PubMed ID: 9619599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infrequent mutation of the p16/MTS1 gene and overexpression of cyclin-dependent kinase 4 in human primary soft-tissue sarcoma.
    Yao J; Pollock RE; Lang A; Tan M; Pisters PW; Goodrich D; El-Naggar A; Yu D
    Clin Cancer Res; 1998 Apr; 4(4):1065-70. PubMed ID: 9563903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.
    Xerri L; Chetaille B; Serriari N; Attias C; Guillaume Y; Arnoulet C; Olive D
    Hum Pathol; 2008 Jul; 39(7):1050-8. PubMed ID: 18479731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
    Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development-dependent expression of cyclin D3 in precursor T-cell lymphoblastic leukemia/lymphoma.
    Sasaki E; Yatabe Y; Hashimoto M; Yamashita Y; Hasegawa Y; Kojima H; Nagasawa T; Mori N
    Pathol Int; 2007 Feb; 57(2):53-9. PubMed ID: 17300668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies.
    Kremer M; Dirnhofer S; Nickl A; Hoefler H; Quintanilla-Martínez L; Fend F
    Mod Pathol; 2001 Oct; 14(10):1022-9. PubMed ID: 11598173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low levels of cyclin D and nonfunctional Rb protein affect cdk6 association with cyclin-dependent kinase inhibitor p27(Kip1).
    Kwon TK; Park JW
    Biochem Biophys Res Commun; 2001 Jun; 284(1):106-11. PubMed ID: 11374878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphoma.
    Fosmire SP; Thomas R; Jubala CM; Wojcieszyn JW; Valli VE; Getzy DM; Smith TL; Gardner LA; Ritt MG; Bell JS; Freeman KP; Greenfield BE; Lana SE; Kisseberth WC; Helfand SC; Cutter GR; Breen M; Modiano JF
    Vet Pathol; 2007 Jul; 44(4):467-78. PubMed ID: 17606508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular cloning, expression pattern, and chromosomal localization of human CDKN2D/INK4d, an inhibitor of cyclin D-dependent kinases.
    Okuda T; Hirai H; Valentine VA; Shurtleff SA; Kidd VJ; Lahti JM; Sherr CJ; Downing JR
    Genomics; 1995 Oct; 29(3):623-30. PubMed ID: 8575754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations of the putative tumor suppressor gene p16/MTS1 in human hematological malignancies.
    Duro D; Flexor MA; Bernard O; d'Agay MF; Berger R; Larsen CJ
    C R Acad Sci III; 1994 Oct; 317(10):913-9. PubMed ID: 7882134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of synthesis and activity of the PLSTIRE protein (cyclin-dependent kinase 6 (cdk6)), a major cyclin D-associated cdk4 homologue in normal human T lymphocytes.
    Lucas JJ; Szepesi A; Modiano JF; Domenico J; Gelfand EW
    J Immunol; 1995 Jun; 154(12):6275-84. PubMed ID: 7759865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors.
    Schmidt BA; Rose A; Steinhoff C; Strohmeyer T; Hartmann M; Ackermann R
    Cancer Res; 2001 May; 61(10):4214-21. PubMed ID: 11358847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA.
    Costello JF; Plass C; Arap W; Chapman VM; Held WA; Berger MS; Su Huang HJ; Cavenee WK
    Cancer Res; 1997 Apr; 57(7):1250-4. PubMed ID: 9102208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias.
    Hayette S; Thomas X; Bertrand Y; Tigaud I; Callanan M; Thiebaut A; Charrin C; Archimbaud E; Magaud JP; Rimokh R
    Leukemia; 1997 Oct; 11(10):1696-9. PubMed ID: 9324291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid nuclear translocation and increased activity of cyclin-dependent kinase 6 after T cell activation.
    Nagasawa M; Melamed I; Kupfer A; Gelfand EW; Lucas JJ
    J Immunol; 1997 Jun; 158(11):5146-54. PubMed ID: 9164930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BCL-6 protein is expressed in precursor T-cell lymphoblastic lymphoma and in prenatal and postnatal thymus.
    Hyjek E; Chadburn A; Liu YF; Cesarman E; Knowles DM
    Blood; 2001 Jan; 97(1):270-6. PubMed ID: 11133771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NOTCH1 intracellular domain immunohistochemistry as a diagnostic tool to distinguish T-lymphoblastic lymphoma from thymoma.
    Jegalian AG; Bodo J; Hsi ED
    Am J Surg Pathol; 2015 Apr; 39(4):565-72. PubMed ID: 25517959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LMO2 Is a Specific Marker of T-Lymphoblastic Leukemia/Lymphoma.
    Jevremovic D; Roden AC; Ketterling RP; Kurtin PJ; McPhail ED
    Am J Clin Pathol; 2016 Feb; 145(2):180-90. PubMed ID: 26796495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.